NCT06480981View on ClinicalTrials.gov

Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

December 23, 2024

Study Completion Date

January 13, 2025

Conditions
Pharmacokinetics
Interventions
DRUG

Noribogaine

Noribogaine capsules

Trial Locations (1)

Unknown

Richmond Pharmacology, London

Sponsors

Lead Sponsor

DemeRx NB
All Listed Sponsors
lead

DemeRx NB

INDUSTRY

NCT06480981 - Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers | Biotech Hunter | Biotech Hunter